Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.

Matikas, A, Foukakis, T, Moebus, V, Greil, R, Bengtsson, NO, Steger, GG, Untch, M, Johansson, H, Hellström, M, Malmström, P, Gnant, M, Loibl, S, Bergh, J.

https://www.ncbi.nlm.nih.gov/pubmed/30357310